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LABELlNG INDEX IN SQUAMOUS CELL CARCINOMA 
OF THE LARYNX 
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Patrizia Boanini, MD, Ezio Gallina, MD, Oreste Gallo, MD, Omero Fini-Storchi, MD, 
and Roberto Bondi, MD 
Two cell kinetic parameters, the 3H-thymidine labeling index 
(TLI) and the mitotic index (MI), were studied in vitro on frag- 
ments of squamous cell carcinoma tissue of the larynx. They 
were evaluated to identify those elements able to characterize 
the growth of these solid tumors. The values of these parame- 
ters were analyzed as a function of the clinical stage and the in- 
volvement of the regional lymph nodes. Results showed a sta- 
tistically significant increase in the TLI from stage ll to T3. No 
statistically significant differences in the TLI values were ob- 
served between the patients with positive and negative lymph 
nodes. HEAD & NECK 1991;13:344-348 
As yet, no reliable histomorphologic or biochem- 
ical parameters have been determined which, 
based on tumor growth and its correlation to 
clinical data, can be used safely in therapeutic 
planning to improve prognosis. 
The proliferative rate of tumors is subject to a 
marked variability due to intrinsic characteris- 
tics, such as cell cycle time, growth fraction, cell 
loss, and degree of differentiation. Tumor growth 
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is further influenced by the microenvironment 
and by the immunologic response of the patient. 
Therefore, the evolution of a malignant neopla- 
sia can show much variability depending on fac- 
tors linked to the disease, to the patient, and to 
treatment and its effectiveness in controlling tu- 
mor growth. 
Even with these limitations, evaluation of the 
number of cells that are duplicating DNA at the 
time of surgical removal gives a direct indication 
of the growth capacity of the tumor. Several 
studies, performed on a large number of patients 
and with an adequate follow-up, demonstrate 
that the 3H-thymidine labeling index (TLI) value 
at the time of surgery is a valuable prognostic 
instrument for neoplasias of the breast, ovaries, 
head, and neck.'-6 
The aim of the present study was to analyze 
the correlations between cell kinetic parameters 
and clinical stage, involvement of regional 
lymph nodes before treatment, rate of relapse, 
metastasis, and survival when long-term fol- 
low-up data are available. 
MATERIALS AND METHODS 
Thirty one consecutive patients (27 men, 4 
women), between 47 and 72 years of age (median 
62 years), were examined in this study. All had 
tumors of the larynx, localized in the supraglot- 
tic region, and classified as squamous cell carci- 
nomas. 
Clinical staging, according to the TNM classi- 
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fication (UICC 1978), is reported in Table 1. Af- 
ter histopathologic examination of the dissected 
lymph nodes, N was modified (N-, no lymph 
node metastasis; N+,  presence of lymph node 
metastasis), and this pathologic N, reported in 
Table 1, was used in the analysis of our data. 
Histologic degree of differentiation, according 
to Broder’s grading, was performed. The inci- 
dence of well-, moderately, and poorly differenti- 
ated tumors was respectively 16.2% (5  of 311, 
58% (18 of 31), and 25.8% (8 of 31). 
A total laryngectomy was performed on 22 of 
the above patients. The remaining 9 patients un- 
derwent supraglottic horizontal laryngectomy. 
Mono- or bilateral radical neck dissection was 
performed on all patients. 
Labeling Index (TLI) Determination. Tumor sam- 
ples were obtained at the time of surgery. Imme- 
diately after removal 12 small fragments (vol- 
ume 1-3 mm3), were incubated separately in 1 
mL of Mc Coy’s 5A medium (70%), fetal calf se- 
rum (20%), and 3H-thymidine (lo%, 0.37 MBq, 
specific activity 740 GBq/mM) for 1 hour at 
37°C in 5% CO, under continuous stirring. The 
fragments were then washed with cold NaCl 
0.9%, fixed in Carnoy’s, and embedded in poly- 
~ t y r e n e . ~  
Three-micron sections were processed by au- 
toradiography using the dipping film technique 
(Ilford K5 emulsion). After a 10-day period of ex- 
posure, the autoradiographies were developed 
and the samples were stained with hematoxylin 
& eosin. 
Tumor histology was examined in the sec- 
tions where TLI and MI were determined. The 
total number of tumor cells, labeled tumor cells, 
and mitoses were counted in each section, using 
the optical microscope (magnification 1,000 x 1. 
Because 3H-thymidine has a limited capabili- 
ty of diffusion, counting was performed either 
in the outer peripheral zone (100 pm) or in 
Table 1. Clinical and histopathologic staging. 
T1 T2 T3 T4 
Clinical staging 
NO 5 2 7 6  
N1 1 1 2 4  
N2 1 -  1 1  
N- 4 2 7 4  
N+ 3 1 3 7  
Lymph node histopathologic staging 
the entire section if the distribution of the la- 
beled cells was homogenous. 
To evaluate the variability of tumor growth 
for each case, the TLI was obtained by counting 
at least 3 fragments cut from different areas of 
the tumor. Moreover 2 or more sections were 
counted from each fragment. Only 1 of 5 sections 
present on each slide was counted to avoid re- 
peating the cell count twice. Usually more than 
10,000 cells were recorded for each case. The TLI 
determined using this method was therefore a 
good indication of the proliferative condition of 
‘the whole tumor. 
Table 2 reports an  example of cell growth 
variability in the tumor. Reported are the total 
cell number (TCN), the TLI, and the MI in each 
section of the different fragments of tumor. 
For each case, the average TLI and MI values 
obtained from the different sections and frag- 
ments were calculated. Because the TLI log 
showed normal distribution, the results of the in- 
dividual group of patients were expressed as the 
geometric mean. The 95% confidence interval 
was calculated, and the Wilcoxon rank sum test 
for 2 independent univariate samples was used 
for statistical analysis. 
RESULTS 
The geometric mean of the TLI in the 31 cases of 
squamous cell carcinoma of the supraglottic lar- 
ynx was 13.21% with a 95% confidence interval 
from 11.70 to 14.92 and a range between 6.88% 
and 30.33%. 
The MI in these cases was 0.402% with a con- 
fidence interval from 0.297 to 0.545 and a range 
between 0.023% and 1.210%. Of these patients, 
only 2, with a TLI of 27.98% (T3NO-) and 
Table 2. Results of case 17 
TCN LI % MI % 
Fragment 1 4,511 17.07 
3,848 17.13 
Total per fragment 8,359 17.09 
Fragment 2 3,823 16.56 
2,773 14.50 
Total per fragment 6,596 15.69 
Fragment 3 4,287 13.83 
3,500 14.74 
Total per fragment 7.787 14.24 
Total 22,742 15.71 
JCN, total cell number; Ll, labeling index; MI, mitotic index. 
Man, age 65, T3NOMO. 
0.665 
0.962 
0.802 
1.256 
1.262 
1.258 
0.653 
0.800 
0.719 
0.906 
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Table 3. LI and MI related to histoloaic grading 
Labeling index 
Histologic No. of Geometric 95% confidence 
grade cases mean interval Range 
Well differentiated 5 12.97 10.91-15.41 10.58-15.58 
Moderately differentiated 18 13.32 11.29-15.71 7.30-30.33 
Poorly differentiated 8 13.09 9.09-18.85 6.88-27.98 
Mitotic index 
Geometric 95% confidence 
mean interval Range 
0.425 - 0.1 20-0.91 5 
0.428 0.267-0.686 0.023-1.210 
0.337 0.203-0.559 0.120-0.671 
Table 4. LI and MI related to clinical staging of lymph nodes. 
Labeling index Mitotic index 
Clinical No. of Geometric 95% confidence Geometric 95% confidence 
N stage cases mean interval Range mean interval Range 
NO 20 12.70 10.83-14.89 6.88- 27.98 0.318 0.209-0.484 0.023-0.932 
N1, N2 11 14.17 11.42- 17.58 9.31 -30.33 0.614 0.442- 0.853 0.21 5- 1.21 0 
Table 5. LI and MI related to patholoaic staaina of IvmDh nodes. 
Labeling index Mitotic index 
Pathologic No. of Geometric 95% confidence Geometric 95% confidence 
N stage Cases mean interval Range mean interval Range 
N- 17 12.98 10.94-15.40 6.88-27.98 0.339 0.207-0.555 0.023-0.932 
N+ 14 13.48 11 .I 0- 16.36 7.50-30.33 0.495 0.348- 0.705 0.120-1.210 
See Table 2 for abbreviations 
Table 6. LI and MI related to T stage. 
Labeling index Mitotic index 
No. of Geometric 95% confidence Geometric 95% confidence 
Tstage Cases mean interval Range mean interval Range 
T1 7 11.49 8.82- 14.97 7.30- 15.24 0.395 0.191 -0.81 7 0.215-1.21 0 
T2 3 12.34 - 7.53-15.92 0.540 - 0.453-0.671 
T3 10 15.73 13.31 -18.58 12.58-27.98 0.396 0.179-0.879 0.023-1.086 
T4 11 12.54 9.70-16.21 6.88-30.33 0.383 0.235-0.624 0.120-0.915 
30.33% (T4N1+) respectively, showed MI values 
greater than 1%. There was little probability of 
observing cells in mitosis, since this phase is 
brief compared to the S phase. This fact deter- 
mined great fluctuactions in MI within the same 
histologic section and between fragments of the 
same tumor. 
The TLI and MI are reported in Table 3 ac- 
cording to histologic grade of differentiation. The 
differences between poorly, moderately, and 
well-differentiated groups were not statistically 
significant. 
When these 2 parameters were compared to 
the clinical involvement of the lymph nodes (Ta- 
ble 41, the values of the NO cases were lower 
than the other cases, but only the differences in 
the MI appeared to be statistically significant 
(p(2) = 0.01). 
Analysis of the cases based on the histopatho- 
logic involvement of lymph nodes showed that 
both TLI and MI values in N- patients were 
lower than in N+ patients, but the differences 
were not statistically significant (Table 5) .  
As reported in Table 6, when related to clini- 
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Table 7. LI and MI related to T and lymph node involvement. 
LI geometric MI geometric 
mean LI Range mean MI Range 
TlN+ (3) 10.21 7.30-15.24 0.442 0.215-1.21 0 
T2N+ (1) 15.65 0.671 
T1N- (4) 12.56 9.13-15.10 0.376 0.128-0.932 
T2N- (2) 10.95 7.53-15.92 0.484 0.453-0.518 
T3N+ (3) 14.88 14.20-16.06 0.673 0.478-1.086 
T3N- (7) 16.10 12.58-27.98 0.318 0.023-0.906 
T4N+ (7) 14.25 9.43-30.33 0.437 0.120-0.763 
T4N- (4) 10.02 6.88-13.21 0.295 0.1 20-0.91 5 
See Table 2 for abbreviations 
cal staging, the TLI increased progressively with 
the tumor size and the differences between T1 
and T3 were statistically significant (p(z) = 
0.025). In the T4 cases, the TLI values were 
lower than the T3 values, but this difference was 
not statistically significant. The wide range of 
TLI observed in the T4 group confirmed the high 
variability of the T4 tumor growth. 
The MI did not show significant differences in 
the different stages. 
Analysis of the TLI according to stage and 
lymph node involvement did not demonstrate a 
homogenous pattern, probably due to the limited 
number of cases for each group (Table 7). How- 
ever, the MI in the N- cases was lower than in 
the N+ cases. Further analysis of T4 cases 
showed that in the N- patients (both NO and 
Nl),  the TLI was lower than in the N+ patients. 
DISCUSSION 
Analysis of the cell kinetic parameters can con- 
tribute to a better characterization of neoplastic 
growth, and the possible prognostic significance 
of pretreatment values cell kinetic parameters in 
human tumors has been studied in recent 
In some cases these parameters can 
also be used to monitor the response to ther- 
a ~ y . ~ "  
Previous studies show that in the larynx the 
geometric mean of the TLI in the normal epithe- 
lium is 6.30% (range 4.9%-7.6%).' In squamous 
cell papilloma, the TLI is 4.70% (range 1.8%- 
16.6%), in inflammatory tissues the geometric 
mean is 7.9% (range 3.0%-15.3%), whereas in 
squamous cell carcinoma it is 5.0% (range 1.0%- 
7.3%).' More recently, other authors give a me- 
dian value, respectively, of 11.2% (range 3.2%- 
16.4%); 8.5% (range 3.0%-15.1%),10 and 11% 
(range 2.37'0-22.4%).~ The results of the present 
and previous demonstrate that the 
carcinomas of the larynx have mean TLI values 
that are noticeable higher than those of the 
breast,li4 bladder," thyroid, and colon- rec- 
tum.13 
Usually the studies refer to the entire group 
of head and neck tumors; this can explain the 
wide range of TLI values, because tumors with 
totally different localizations and prognosis are 
included. The present study tried to eliminate a 
part of the variables by analyzing only the 
squamous cell carcinomas of the supraglottic re- 
gion of the larynx. 
The variability of the results obtained by the 
various authors is rather high and demonstrates 
the need to  standardize the handling of tissue 
fragments and, above all, of the counting method 
used. 
We feel that our results are validified by the 
large sample examined: in fact, many thousands 
of cells in different fragment levels and many tu- 
mor fragments were counted. The current 
method is long and time-consuming, but other 
alternative techniques for the study of the frac- 
tion of S phase cells, such as flow cytometry, 'are 
not yet completely satisfying. Moreover, autora- 
diographic techniques allow the study of the tu- 
mor structure and its relationship with the nor- 
mal surrounding tissue. 
The present study evidenced some correla- 
tions between the cell kinetic parameters and tu- 
mor staging. The TLI and MI in the NO cases 
were lower than in N1 and N2 cases, although 
the differences were not statistically significant. 
The TLI increased as the T increased, and 
statistically significant differences were demon- 
strated between T1 and T3, demonstrating a 
higher proliferative activity in larger tumors. T4 
cases showed low TLI values, except in 1 patient 
whose TLI value was 30.33%. In general, the N- 
cases had a lower TLI than the N+ ones. 
This study did not confirm the previously de- 
scribed observations concerning correlation be- 
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tween histologic grading and TLI. Above all, cell 
kinetic parameters do not appear to be related to 
the presence of micrometastases in the lymph 
nodes." However, the number of cases studied to 
date is too limited to allow definite conclusions. 
Given the short follow-up period, it was not 
possible to  correlate cell kinetic parameters with 
the survival rate and the incidence of relapses 
and metastases or to verify the eventual use of 
TLI to predict prognosis. 
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